Progesterone for premenstrual syndrome

Lifestyle Factors, Hormonal Contraception, and Premenstrual Symptoms: The United Kingdom Southampton Women's Survey

“…To date, the therapeutic trials of hormone treatments for PMS, rather than PMDD, have proved inconclusive, 14,15,32 but this may be because they assessed cyclical rather than continuous regimens. Observational evidence from our work and elsewhere 18,27,30,33 suggests that hormonal contraceptive methods that suppress ovulation and act continuously may have a role in preventing premenstrual symptoms.…”

“…10 Selective serotonin reuptake inhibitors (SSRIs) have been shown to be effective given both continuously and cyclically. 11,12 Cyclical progesterone therapy has been advocated, 13 but multiple trials and meta-analyses have shown progesterone to be ineffective, 14,15 although these studies mainly looked at cyclical use of progesterone rather than continuous use. Estrogen, delivered either as patches or implants, has been shown in several studies to help relieve PMS.…”

Lifestyle Factors, Hormonal Contraception, and Premenstrual Symptoms: The United Kingdom Southampton Women's Survey

“…To date, the therapeutic trials of hormone treatments for PMS, rather than PMDD, have proved inconclusive, 14,15,32 but this may be because they assessed cyclical rather than continuous regimens. Observational evidence from our work and elsewhere 18,27,30,33 suggests that hormonal contraceptive methods that suppress ovulation and act continuously may have a role in preventing premenstrual symptoms.…”

“…10 Selective serotonin reuptake inhibitors (SSRIs) have been shown to be effective given both continuously and cyclically. 11,12 Cyclical progesterone therapy has been advocated, 13 but multiple trials and meta-analyses have shown progesterone to be ineffective, 14,15 although these studies mainly looked at cyclical use of progesterone rather than continuous use. Estrogen, delivered either as patches or implants, has been shown in several studies to help relieve PMS.…”

Affective Sensitivity to Ovarian Steroid Hormone Flux Across the Menstrual Cycle: Manifestations and Biopsychosocial Risk Factors

“…This rapid increase in symptoms only lasts for the first month of treatment despite continuous hormone administration ( Schmidt et al 2017 ), and inducing premature hormone withdrawal in the mid-luteal phase does not alter symptom trajectory ( Schmidt et al 1991 ), suggesting that increases or surges in hormones drive symptoms, not high absolute levels or late luteal withdrawal. Of note, the late luteal withdrawal hypothesis persists as a frequently cited narrative in both scientific and clinical communications, driving some continued clinical use of P4 supplementation despite meta-analytic evidence showing inconclusive effects in clinical trials ( Ford et al 2012 ).…”

Premenstrual Syndrome Symptomatology among Married Women of Fertile Age based on Methods of Contraception (Hormonal versus Non-Hormonal Methods of Contraception)

“…Based on the hypotheses related to the etiology of PMS/PMDD, that is thought that SSAIs and the compounds that prevent ovulation, such as gonadotropin-releasing hormone agonists (gnrh-As), seem to be effective treatments for this disorder ( Backstrom et al, 2003 ). Moreover, there have been varying reports on the effects of hormonal contraception methods, such as OCPs, on women suffering from PMS ( Backstrom et al, 2003 ; Bäckström, Hansson-Malmström, Lindhe, Cavalli-Björkman, & Nordenström, 1992 ; C. Brown, Ling, & Wan, 2001 ; Calhoun, 2012 ; Dennerstein et al, 1985 ; Ford, Lethaby, Mol, & Roberts, 2006 ; Freeman et al, 2001 ; Graham & Sherwin, 1992 ; Jarvis, Lynch, & Morin, 2008 ; Lopez, Kaptein, & Helmerhorst, 2012 ; Magill, 1995 ; Vanselow, Dennerstein, Greenwood, & de Lignieres, 1996 ; K. Wyatt, Dimmock, Jones, Obhrai, & O’Brien, 2001 ; K. M. Wyatt, Dimmock, Ismail, Jones, & O’Brien, 2004 ).…”

“… Dennerstien et al (1985) confirmed beneficial effects of progesterone on the both mood and physical symptoms of PMS but some studies failed to show effectiveness of progesterone ( Sampson, 1979 ; Van der Meer, Benedek-Jaszmann, & Van Loenen, 1983 ). Findings of a review ( Ford et al, 2006 ) revealed that effectiveness of progesterone in treatment of PMS differs based on participants, rout of administration, duration and doses. Patients with PMS treated by using oral contraceptive (OC) containing combination of drospirenone and ethinyl estradiol show more improvement compared with those treated with placebo, and symptom reductions were significant in acne, appetite and food craving ( Freeman et al, 2001 ).…”

Lifestyle Factors, Hormonal Contraception, and Premenstrual Symptoms: The United Kingdom Southampton Women's Survey

“…To date, the therapeutic trials of hormone treatments for PMS, rather than PMDD, have proved inconclusive, 14,15,32 but this may be because they assessed cyclical rather than continuous regimens. Observational evidence from our work and elsewhere 18,27,30,33 suggests that hormonal contraceptive methods that suppress ovulation and act continuously may have a role in preventing premenstrual symptoms.…”

“…10 Selective serotonin reuptake inhibitors (SSRIs) have been shown to be effective given both continuously and cyclically. 11,12 Cyclical progesterone therapy has been advocated, 13 but multiple trials and meta-analyses have shown progesterone to be ineffective, 14,15 although these studies mainly looked at cyclical use of progesterone rather than continuous use. Estrogen, delivered either as patches or implants, has been shown in several studies to help relieve PMS.…”

Affective Sensitivity to Ovarian Steroid Hormone Flux Across the Menstrual Cycle: Manifestations and Biopsychosocial Risk Factors

“…This rapid increase in symptoms only lasts for the first month of treatment despite continuous hormone administration ( Schmidt et al 2017 ), and inducing premature hormone withdrawal in the mid-luteal phase does not alter symptom trajectory ( Schmidt et al 1991 ), suggesting that increases or surges in hormones drive symptoms, not high absolute levels or late luteal withdrawal. Of note, the late luteal withdrawal hypothesis persists as a frequently cited narrative in both scientific and clinical communications, driving some continued clinical use of P4 supplementation despite meta-analytic evidence showing inconclusive effects in clinical trials ( Ford et al 2012 ).…”

Premenstrual Syndrome Symptomatology among Married Women of Fertile Age based on Methods of Contraception (Hormonal versus Non-Hormonal Methods of Contraception)

“…Based on the hypotheses related to the etiology of PMS/PMDD, that is thought that SSAIs and the compounds that prevent ovulation, such as gonadotropin-releasing hormone agonists (gnrh-As), seem to be effective treatments for this disorder ( Backstrom et al, 2003 ). Moreover, there have been varying reports on the effects of hormonal contraception methods, such as OCPs, on women suffering from PMS ( Backstrom et al, 2003 ; Bäckström, Hansson-Malmström, Lindhe, Cavalli-Björkman, & Nordenström, 1992 ; C. Brown, Ling, & Wan, 2001 ; Calhoun, 2012 ; Dennerstein et al, 1985 ; Ford, Lethaby, Mol, & Roberts, 2006 ; Freeman et al, 2001 ; Graham & Sherwin, 1992 ; Jarvis, Lynch, & Morin, 2008 ; Lopez, Kaptein, & Helmerhorst, 2012 ; Magill, 1995 ; Vanselow, Dennerstein, Greenwood, & de Lignieres, 1996 ; K. Wyatt, Dimmock, Jones, Obhrai, & O’Brien, 2001 ; K. M. Wyatt, Dimmock, Ismail, Jones, & O’Brien, 2004 ).…”

“… Dennerstien et al (1985) confirmed beneficial effects of progesterone on the both mood and physical symptoms of PMS but some studies failed to show effectiveness of progesterone ( Sampson, 1979 ; Van der Meer, Benedek-Jaszmann, & Van Loenen, 1983 ). Findings of a review ( Ford et al, 2006 ) revealed that effectiveness of progesterone in treatment of PMS differs based on participants, rout of administration, duration and doses. Patients with PMS treated by using oral contraceptive (OC) containing combination of drospirenone and ethinyl estradiol show more improvement compared with those treated with placebo, and symptom reductions were significant in acne, appetite and food craving ( Freeman et al, 2001 ).…”

Lifestyle Factors, Hormonal Contraception, and Premenstrual Symptoms: The United Kingdom Southampton Women's Survey

“…To date, the therapeutic trials of hormone treatments for PMS, rather than PMDD, have proved inconclusive, 14,15,32 but this may be because they assessed cyclical rather than continuous regimens. Observational evidence from our work and elsewhere 18,27,30,33 suggests that hormonal contraceptive methods that suppress ovulation and act continuously may have a role in preventing premenstrual symptoms.…”

“…10 Selective serotonin reuptake inhibitors (SSRIs) have been shown to be effective given both continuously and cyclically. 11,12 Cyclical progesterone therapy has been advocated, 13 but multiple trials and meta-analyses have shown progesterone to be ineffective, 14,15 although these studies mainly looked at cyclical use of progesterone rather than continuous use. Estrogen, delivered either as patches or implants, has been shown in several studies to help relieve PMS.…”

Affective Sensitivity to Ovarian Steroid Hormone Flux Across the Menstrual Cycle: Manifestations and Biopsychosocial Risk Factors

“…This rapid increase in symptoms only lasts for the first month of treatment despite continuous hormone administration ( Schmidt et al 2017 ), and inducing premature hormone withdrawal in the mid-luteal phase does not alter symptom trajectory ( Schmidt et al 1991 ), suggesting that increases or surges in hormones drive symptoms, not high absolute levels or late luteal withdrawal. Of note, the late luteal withdrawal hypothesis persists as a frequently cited narrative in both scientific and clinical communications, driving some continued clinical use of P4 supplementation despite meta-analytic evidence showing inconclusive effects in clinical trials ( Ford et al 2012 ).…”

Premenstrual Syndrome Symptomatology among Married Women of Fertile Age based on Methods of Contraception (Hormonal versus Non-Hormonal Methods of Contraception)

“…Based on the hypotheses related to the etiology of PMS/PMDD, that is thought that SSAIs and the compounds that prevent ovulation, such as gonadotropin-releasing hormone agonists (gnrh-As), seem to be effective treatments for this disorder ( Backstrom et al, 2003 ). Moreover, there have been varying reports on the effects of hormonal contraception methods, such as OCPs, on women suffering from PMS ( Backstrom et al, 2003 ; Bäckström, Hansson-Malmström, Lindhe, Cavalli-Björkman, & Nordenström, 1992 ; C. Brown, Ling, & Wan, 2001 ; Calhoun, 2012 ; Dennerstein et al, 1985 ; Ford, Lethaby, Mol, & Roberts, 2006 ; Freeman et al, 2001 ; Graham & Sherwin, 1992 ; Jarvis, Lynch, & Morin, 2008 ; Lopez, Kaptein, & Helmerhorst, 2012 ; Magill, 1995 ; Vanselow, Dennerstein, Greenwood, & de Lignieres, 1996 ; K. Wyatt, Dimmock, Jones, Obhrai, & O’Brien, 2001 ; K. M. Wyatt, Dimmock, Ismail, Jones, & O’Brien, 2004 ).…”

“… Dennerstien et al (1985) confirmed beneficial effects of progesterone on the both mood and physical symptoms of PMS but some studies failed to show effectiveness of progesterone ( Sampson, 1979 ; Van der Meer, Benedek-Jaszmann, & Van Loenen, 1983 ). Findings of a review ( Ford et al, 2006 ) revealed that effectiveness of progesterone in treatment of PMS differs based on participants, rout of administration, duration and doses. Patients with PMS treated by using oral contraceptive (OC) containing combination of drospirenone and ethinyl estradiol show more improvement compared with those treated with placebo, and symptom reductions were significant in acne, appetite and food craving ( Freeman et al, 2001 ).…”